Avantor is a steady earnings-beater with strong cash conversion (131% FCF/NI) and a forward P/E of 18.1x, but quality is below average and the price of $16.05 is 6.0% above the $15.09 analyst target. Weak momentum and a negative reward-to-risk leave little room for new capital.
Thesis pillars
- Strong Cash Conversion↑Improving
- Steady Earnings Beat Record↑Improving
- Price Above Analyst Target↑Improving
- +2 more pillars — see the Why tab for full reasoning
Pillars as of Nov 1, 2026, based on the 10-K filed Feb 11, 2026
Avantor, Inc. (AVTR) Stock Analysis
Healthcare · Medical Instruments & Supplies
Sell if holding. Analyst target reached at $15.59 — A.R:R is negative (-0.4) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Supplier: sole-sourced raw materials.
Avantor distributes laboratory supplies and manufactures specialty materials — J.T. Baker high-purity chemicals, NuSil silicone, and Masterflex fluid systems — to 300,000+ customer locations in ~180 countries through Laboratory Solutions and Bioscience Production segments. The... Read more
Sell if holding. Analyst target reached at $15.59 — A.R:R is negative (-0.4) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Supplier: sole-sourced raw materials. Chart setup: No clear chart pattern; technical signals are mixed. Score 5.5/10, moderate confidence.
Passes 5/8 gates (clean insider activity, news events none recent, earnings proximity 98d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: moderate.
Recent developments
updated Nov 3, 2026Recent Developments — Avantor, Inc.
Latest news
- NEWS Avantor Grants Restricted Stock Units to Chief Legal and Compliance Officer — fiscal.ai Nov 3, 2026 neutral
- NEWS Incyte To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Friday — benzinga Oct 30, 2026 neutral
- NEWS Analysts Update Ratings and Price Targets for Avantor — fiscal.ai Oct 29, 2026 neutral
- NEWS RBC Capital Maintains Sector Perform on Avantor, Raises Price Target to $17 — benzinga Oct 29, 2026 positive
- NEWS Analysts Adjust Price Targets for Avantor — fiscal.ai Oct 29, 2026 neutral
Latest item Nov 3, 2026 · Generated 2026-11-04T11:49:36Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHSuppliersole-sourced raw materials10-K Item 1A: 'raw materials, many of which are sole-sourced due to market or customer demands'
Material Events(8-K, last 90d)
- 2026-04-01Item 5.02HIGHCFO R. Brent Jones resigned March 26, 2026 to join a company outside life sciences (90-day notice required). SVP/CAO Steven Eck named interim CFO; executive search for permanent CFO underway. No permanent successor named.SEC filing →
- 2026-04-23Item 5.02MEDIUMEVP Benoit Gourdier notified April 17, 2026 of transition to segment integration role, expected to depart by Dec 31, 2026. Successor Ludovic Brellier named EVP Bioscience and Medtech Products and Chief Transformation Officer, effective May 1, 2026.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Momentum below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Analyst target reached at $15.59 — A.R:R is negative (-0.4) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Supplier: sole-sourced raw materials. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $14.51. Score 5.5/10, moderate confidence.
Analyst target $15.09 reached (−3.2% from $15.59); no take-profit level is published. Prior stop was $14.51. Stop-loss: $14.51.
Concentration risk — Supplier: sole-sourced raw materials; Analyst target reached - limited upside remaining; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.7).
Avantor, Inc. trades at a P/E of 31.2 (forward 17.6). TrendMatrix value score: 6.4/10. Verdict: Sell.
24 analysts rate AVTR, with a consensus score of 3.4/5. 13 analysts publish price targets averaging $17.
What does Avantor, Inc. do?Avantor distributes laboratory supplies and manufactures specialty materials — J.T. Baker high-purity chemicals, NuSil...
Avantor distributes laboratory supplies and manufactures specialty materials — J.T. Baker high-purity chemicals, NuSil silicone, and Masterflex fluid systems — to 300,000+ customer locations in ~180 countries through Laboratory Solutions and Bioscience Production segments. The company generates revenue through distribution and service contracts, with ~80% of 2025 transactions via digital channels and no single customer exceeding 5% of net sales.